HER2 status as predictive marker for Al vs Tam benefit: A TRANS-AIOG meta-analysis of 12129 patients from ATAC, BIG 1-98 and TEAM with centrally determined HER2

Author(s):
Bartlett, J.M.S.; Ahmed, I.; Regan, M.M.; Sestak, I.; Mallon, E.A.; Dell'Orto, P.; Thurlimann, B.J.K.; Seynaeve, C.; Putter, H.; Brookes, C.L.; Forbes, J.F.; Colleoni, M.A.; Bayani, J.; Velde, C.J.H. van de (0000-0003-0104-1800); Viale, G.; Cuzick, J.; Dowsett, M.; Rea, D.W.; Translational Aromatase Inhibitor
Published
2016
Publication type
Article / Letter to editor
Date issued
2016-02-15
Language
English
Is part of
Cancer Research
hdl
1887/114003
doi
10.1158/1538-7445.SABCS15-S4-06